Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1
All systems demonstrated excellent reliability but possess distinct advantages and limitations. Surface area is the most consistent and reliable parameter for measuring cNF size in clinical trials.
Authors
- Jaishri Blakely
- Tai Anh Phan (ORCID: https://orcid.org/0000-0001-9509-6006)
- Christina Bergqvist (ORCID: https://orcid.org/0000-0003-4985-6785)
- Timothy E. Schlub (ORCID: https://orcid.org/0000-0001-7746-9649)
- Yemima Berman (ORCID: https://orcid.org/0000-0003-2495-4928)
- Jonathan Lau (ORCID: https://orcid.org/0000-0002-6209-0246)
- Carlos G. Romo (ORCID: https://orcid.org/0000-0002-0260-7047)
- Sue‐Faye Siow (ORCID: https://orcid.org/0000-0003-1485-0228)
- Rebecca B. Saunderson (ORCID: https://orcid.org/0000-0001-9670-0041)
- Jane Fleming (ORCID: https://orcid.org/0000-0003-1164-2386)
- Adrian Lim (ORCID: https://orcid.org/0000-0001-5703-8649)
- Nanette Lacson
- Martin Good
Institutions
- The University of Sydney (AU)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Royal North Shore Hospital (AU)
- Assistance Publique – Hôpitaux de Paris (FR)
Publication Details
- Journal
- Skin Research and Technology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1111/srt.70020
- Primary Topic
- Neurofibromatosis and Schwannoma Cases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Office of Health and Medical Research
- Neurofibromatosis Therapeutic Acceleration Program